Company intelligence / Profile preview

Admira Visión

Ownership: Private
Development stage: Other

Overview

Admira Visión operates as a leading ophthalmology group in Spain with over two decades of experience. It provides comprehensive clinical care for all major eye conditions using advanced technology such as intraocular lenses and CO₂ laser therapies. The group emphasizes high-quality patient care and continuous innovation in ophthalmic diagnostics and treatment. Clinical results are consistent with standard-of-care outcomes for a reference center in Spain.

Therapeutic areas: Ophthalmology
Modalities: Device (ophthalmic surgery devices)Non-pharmacological therapy (laser treatments)Small molecule (eye drops/medications for ocular diseases)
Industry: Non-Academic Healthcare

Partnerships

Likely collaborates with hospitals such as Clínica Sagrada Familia Barcelona.

Beyond the preview

Go deeper on Admira Visión.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Admira Visión.

Explore the full profile